Moderators: Gerrie Dresser, CEO/Unique Impact; Executive / Personal Brand Coach http://www.linkedin.com/in/gerriedresser http://www.successassociates.biz/resources/Bio%20Gerrie%20Dresser.pdf http://www.uniqueimpact.biz/ Gerrie Dresser is a nationally recognized Executive l Personal Brand Coach and CEO/Founder of her firm, Unique Impact, with over 20 years corporate leadership experience in Fortune 500 corporations Through a proprietary coaching model, Leadership Impact, her firm has helped over 1,000 high achieving leaders to maximize their distinctive value and deliver strategic impact that accelerates performance and inspires engagement She earned the Professional Certified Coach credential from International Coach Federation (ICF), and served as President for ICF Philadelphia She is a Tilt 365 Certified Practitioner, and has held leadership roles with HBA Mentoring Programs, Leadership Conference Coaching Committee, and global Leadership in Practice Program Mike Keatley, Pharmacovigilance Officer, Janssen Scientific Affairs, LLC www.linkedin.com/pub/michael-keatley/9/9a6/366 http://www.janssenbiotech.com/ Mike Keatley has been in the pharmaceutical industry for 26 years in various roles He began his career at Merck manufacturing vaccines and other parenteral products and then moved into management roles in Quality Control In 1990, he moved to clinical and regulatory development in drug safety at Merck and joined Centocor Inc in 2003 to provide safety support for the immunology products Currently, in his role as a Pharmacovigilance Officer for Janssen Scientific Affairs, LLC, he oversees critical functions of the US commercial operation to ensure compliance with safety regulations for immunology and oncology products Mike earned a BA in Biology/Medical Technology from Messiah College Panelists: David Nicoli, VP, AstraZeneca www.linkedin.com/pub/david-nicoli/11/43b/7b7 http://www.astrazeneca-us.com/about-us/us-leadership-team/Biography/david-p-nicoli http://www.astrazeneca-us.com/home/ David Nicoli has served for years on the senior executive team that manages AstraZeneca Pharmaceuticals' US subsidiary, which had $10 billion in revenue in 2012 During that time, David reported directly to and served as the principal strategic counselor for different CEOs with respect to the external environment in which the business operates In addition, David serves on the Board of Directors of the Christiana Care Health System, Delaware's largest hospital system with an annual revenue of $1.6 billion David serves on both the Governance and the Compliance & Audit Committees Bonnie Sharps, Managing Director and Executive VP, DHR International Formerly, VP and General Manager, Siemens Health Solutions www.linkedin.com/in/bonniesharps http://www.dhrinternational.com/consultants/consultantsviewbio.aspx?consultantid=580 http://www.dhrinternational.com/ Bonnie Sharps serves as Executive Vice President of DHR International and specializes in searches in Healthcare Services, Life Sciences, Industrial and Advanced Technology sectors Prior to that, Bonnie spent over 26 years with Shared Medical Systems (SMS) and Siemens Medical There she rose through software implementation, account management and sales to become Regional Vice President Later, as Vice President of Software Development, she helped lead the building of technology and infrastructures for product development Upon SMS being bought by Siemens, Bonnie served on the international integration team overseeing the merger This was later followed with a General Manager position leading Siemens’ Physician Office business Upon leaving Siemens in 2002, Bonnie joined a start-up company where she remained before going into executive search Denise Tenerelli, VP U.S Commercial Operations, Shire Pharmaceuticals http://www.linkedin.com/profile/view?id=137638537&trk=hb_tab_pro_top http://www.shire.com/shireplc/en/home Denise has over 20 years pharmaceutical industry experience at Glaxo SmithKline, Bristol-Myers Squibb and Shire, spanning Sales, Marketing Services, IT, International Audit and Sales Operations She consistently exceeds challenging business objectives, thinks strategically and innovatively, and is recognized for developing talent and leading large complex matrix teams Her academic achievements include BS in Business from Drexel University, an MBA in Pharmaceutical Marketing from Saint Joseph's University, and completion of the Wharton Executive Management Certificate Program and the KPMG Executive Leadership Institute for Women Certificate Program In addition, she has taught at the Villanova University MBA program “Changing Pharma and the Skills and Capabilities needed for the future”